Cargando…

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry

PURPOSE: The prognosis of local invasive recurrence (LIR) after prior carcinoma in situ (CIS) of the breast has not been widely studied and existing data are conflicting, especially considering the specific prognosis of this entity, compared to de novo invasive breast cancer (de novo IBC) and with L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kada Mohammed, Samia, Dabakuyo Yonli, Tienhan Sandrine, Desmoulins, Isabelle, Manguem Kamga, Ariane, Jankowski, Clémentine, Padeano, Marie-Martine, Loustalot, Catherine, Costaz, Hélène, Causeret, Sylvain, Peignaux, Karine, Rouffiac, Magali, Coutant, Charles, Arnould, Laurent, Ladoire, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823085/ https://www.ncbi.nlm.nih.gov/pubmed/36417042 http://dx.doi.org/10.1007/s10549-022-06807-w

Ejemplares similares

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion
por: Assogba, Emerline L. F., et al.
Publicado: (2020)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
por: Mahiou, Katia, et al.
Publicado: (2023)

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol
por: Assogba, Emerline L F, et al.
Publicado: (2022)

Survival in patients with HR+/HER2− metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study
por: Simon, Julien, et al.
Publicado: (2020)

Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d’Or, France
por: Feron Agbo, Clémence, et al.
Publicado: (2023)

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial
por: Mamguem Kamga, Ariane, et al.
Publicado: (2020)

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study
por: Auguste, Aviane, et al.
Publicado: (2017)

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients
por: De Gournay, E, et al.
Publicado: (2013)

Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers
por: Bergeron, Anthony, et al.
Publicado: (2023)

Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
por: Ilie, Silvia Mihaela, et al.
Publicado: (2023)

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years
por: Hamidou, Zeinab, et al.
Publicado: (2010)

Impact of Response Shift on Time to Deterioration in Quality of Life Scores in Breast Cancer Patients
por: Hamidou, Zeinab, et al.
Publicado: (2014)

Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study
por: Chanteloup, Gaëtan, et al.
Publicado: (2020)

Impact de COVID-19 sur le stade du cancer du sein à la découverte et le délai de traitement en Côte d'Or, France
por: Feron Agbo, C., et al.
Publicado: (2023)

Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level
por: Cottenet, Jonathan, et al.
Publicado: (2022)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context
por: Lhomme, Edouard, et al.
Publicado: (2019)

Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment
por: Barben, Jérémy, et al.
Publicado: (2023)

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso
por: Traoré, Isidore Tiandiogo, et al.
Publicado: (2021)

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
por: Billa, Oumar, et al.
Publicado: (2021)

P1746: LONG-TERM NON-HODGKIN LYMPHOMA SURVIVORS IN CÔTE D’OR: HEALTH-RELATED QUALITY OF LIFE AND LIVING CONDITIONS.
por: Wasse, S., et al.
Publicado: (2022)

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study
por: Wasse, Stephane Kroudia, et al.
Publicado: (2023)

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
por: Eliade, Marie, et al.
Publicado: (2016)

Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status
por: Morel, Louis-Oscar, et al.
Publicado: (2023)

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients
por: Pozet, Astrid, et al.
Publicado: (2023)

For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year population-based multilevel analysis
por: Gentil, Julie, et al.
Publicado: (2012)

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
por: Kaboré, Nongodo Firmin, et al.
Publicado: (2023)

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
por: Galland, Loïck, et al.
Publicado: (2023)

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment
por: Dialla, Pegdwende Olivia, et al.
Publicado: (2012)

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation
por: Ouedraogo, Samiratou, et al.
Publicado: (2023)

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
por: Ballot, Elise, et al.
Publicado: (2022)

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results
por: Réda, Manon, et al.
Publicado: (2023)

Population Pharmacokinetics of Palbociclib in a Real-World Situation
por: Royer, Bernard, et al.
Publicado: (2021)

Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer
por: Klopfenstein, Quentin, et al.
Publicado: (2021)

PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
por: Tharin, Zoé, et al.
Publicado: (2023)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
por: Galland, Loïck, et al.
Publicado: (2022)

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2014)

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
por: Dréno, Brigitte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjrinsrd3aqnua88ur0ecp74vf